Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue.

Ghadially H, Brown L, Lloyd C, Lewis L, Lewis A, Dillon J, Sainson R, Jovanovic J, Tigue NJ, Bannister D, Bamber L, Valge-Archer V, Wilkinson RW.

Br J Cancer. 2017 Apr 25;116(9):1208-1217. doi: 10.1038/bjc.2017.79. Epub 2017 Mar 23.

2.

NK cell receptor NKp46 regulates graft-versus-host disease.

Ghadially H, Ohana M, Elboim M, Gazit R, Gur C, Nagler A, Mandelboim O.

Cell Rep. 2014 Jun 26;7(6):1809-14. doi: 10.1016/j.celrep.2014.05.011. Epub 2014 May 29.

3.

NKp46 regulates allergic responses.

Ghadially H, Horani A, Glasner A, Elboim M, Gazit R, Shoseyov D, Mandelboim O.

Eur J Immunol. 2013 Nov;43(11):3006-16. doi: 10.1002/eji.201343388. Epub 2013 Aug 21.

4.

Evolution of the C-type lectin-like receptor genes of the DECTIN-1 cluster in the NK gene complex.

Sattler S, Ghadially H, Hofer E.

ScientificWorldJournal. 2012;2012:931386. doi: 10.1100/2012/931386. Epub 2012 Apr 1. Review.

5.

Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.

Glasner A, Ghadially H, Gur C, Stanietsky N, Tsukerman P, Enk J, Mandelboim O.

J Immunol. 2012 Mar 15;188(6):2509-15. doi: 10.4049/jimmunol.1102461. Epub 2012 Feb 3.

6.

Altered dendritic cell-natural killer interaction in Kenyan sex workers resistant to HIV-1 infection.

Ghadially H, Keynan Y, Kimani J, Kimani M, Ball TB, Plummer FA, Mandelboim O, Meyers AF.

AIDS. 2012 Feb 20;26(4):429-36. doi: 10.1097/QAD.0b013e32834f98ea.

PMID:
22156969
7.

The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talk.

Elhaik-Goldman S, Kafka D, Yossef R, Hadad U, Elkabets M, Vallon-Eberhard A, Hulihel L, Jung S, Ghadially H, Braiman A, Apte RN, Mandelboim O, Dagan R, Mizrachi-Nebenzahl Y, Porgador A.

PLoS One. 2011;6(8):e23472. doi: 10.1371/journal.pone.0023472. Epub 2011 Aug 22.

8.

Tumor immunoediting by NKp46.

Elboim M, Gazit R, Gur C, Ghadially H, Betser-Cohen G, Mandelboim O.

J Immunol. 2010 May 15;184(10):5637-44. doi: 10.4049/jimmunol.0901644. Epub 2010 Apr 19.

9.

The activating receptor NKp46 is essential for the development of type 1 diabetes.

Gur C, Porgador A, Elboim M, Gazit R, Mizrahi S, Stern-Ginossar N, Achdout H, Ghadially H, Dor Y, Nir T, Doviner V, Hershkovitz O, Mendelson M, Naparstek Y, Mandelboim O.

Nat Immunol. 2010 Feb;11(2):121-8. doi: 10.1038/ni.1834. Epub 2009 Dec 20.

PMID:
20023661
10.

Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.

Halfteck GG, Elboim M, Gur C, Achdout H, Ghadially H, Mandelboim O.

J Immunol. 2009 Feb 15;182(4):2221-30. doi: 10.4049/jimmunol.0801878.

11.

Differential regulation of CCL22 gene expression in murine dendritic cells and B cells.

Ghadially H, Ross XL, Kerst C, Dong J, Reske-Kunz AB, Ross R.

J Immunol. 2005 May 1;174(9):5620-9.

Supplemental Content

Loading ...
Support Center